Core Laboratories Inc.
CLB
$10.44
-$0.16-1.51%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.64M | -154.00K | 7.40M | 11.75M | 9.03M |
| Total Depreciation and Amortization | 3.67M | 3.72M | 3.66M | 3.68M | 3.77M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.72M | 4.94M | -144.00K | -1.41M | -4.14M |
| Change in Net Operating Assets | 1.34M | -1.84M | 9.69M | -915.00K | 8.49M |
| Cash from Operations | 13.92M | 6.66M | 20.62M | 13.10M | 17.15M |
| Capital Expenditure | -4.33M | -3.58M | -4.38M | -2.73M | -2.87M |
| Sale of Property, Plant, and Equipment | 966.00K | 1.23M | 802.00K | 133.00K | 208.00K |
| Cash Acquisitions | -617.00K | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.34M | 3.12M | 20.00K | 2.11M | 1.97M |
| Cash from Investing | -1.64M | 772.00K | -3.56M | -491.00K | -687.00K |
| Total Debt Issued | 12.00M | 13.00M | 6.00M | 16.00M | 8.00M |
| Total Debt Repaid | -12.00M | -15.00M | -20.00M | -24.00M | -21.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -2.74M | -2.02M | -4.90M | -196.00K | -162.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -469.00K | -469.00K | -469.00K | -469.00K | -470.00K |
| Other Financing Activities | 10.00K | 9.00K | 0.00 | -162.00K | -45.00K |
| Cash from Financing | -3.20M | -4.48M | -19.37M | -8.83M | -13.68M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.08M | 2.95M | -2.32M | 3.78M | 2.78M |